184 related articles for article (PubMed ID: 20443084)
1. P53 gene polymorphisms and breast cancer risk in Arab women.
Alawadi S; Ghabreau L; Alsaleh M; Abdulaziz Z; Rafeek M; Akil N; Alkhalaf M
Med Oncol; 2011 Sep; 28(3):709-15. PubMed ID: 20443084
[TBL] [Abstract][Full Text] [Related]
2. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
4. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
5. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
6. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
7. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
[TBL] [Abstract][Full Text] [Related]
8. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
Huang XE; Hamajima N; Katsuda N; Matsuo K; Hirose K; Mizutani M; Iwata H; Miura S; Xiang J; Tokudome S; Tajima K
Breast Cancer; 2003; 10(4):307-11. PubMed ID: 14634508
[TBL] [Abstract][Full Text] [Related]
9. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
11. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
Hao W; Xu X; Shi H; Zhang C; Chen X
Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.
Akkiprik M; Sonmez O; Gulluoglu BM; Caglar HB; Kaya H; Demirkalem P; Abacioglu U; Sengoz M; Sav A; Ozer A
Pathol Oncol Res; 2009 Sep; 15(3):359-68. PubMed ID: 19048399
[TBL] [Abstract][Full Text] [Related]
13. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
14. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
15. [Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer].
Zhang W; Jin MJ; Chen K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 36(6):561-6. PubMed ID: 18067229
[TBL] [Abstract][Full Text] [Related]
16. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years.
Wang-Gohrke S; Becher H; Kreienberg R; Runnebaum IB; Chang-Claude J
Pharmacogenetics; 2002 Apr; 12(3):269-72. PubMed ID: 11927843
[TBL] [Abstract][Full Text] [Related]
17. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z
Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678
[TBL] [Abstract][Full Text] [Related]
18. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women.
Jiang P; Liu J; Li W; Zeng X; Tang J
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):671-6. PubMed ID: 20732856
[TBL] [Abstract][Full Text] [Related]
19. Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.
Cardoso YMN; Resque RL; Yoshio D; B Miranda AR; Secco M; Do N Rodrigues AS
Asian Pac J Cancer Prev; 2023 Jan; 24(1):157-162. PubMed ID: 36708564
[TBL] [Abstract][Full Text] [Related]
20. The TP53 intron 6 G13964C polymorphism and risk of thyroid and breast cancer development in the Iranian Azeri population.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Adampourezare M; Farajzadeh D
Asian Pac J Cancer Prev; 2015; 16(7):3073-7. PubMed ID: 25854408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
